Sun Pharmaceutical Industries to Acquire Innovcare Lifesciences for Rs2.71 Billion

Sun Pharmaceutical Industries to Acquire Innovcare Lifesciences for Rs2.71 Billion

Sun Pharmaceutical Industries announced an agreement to acquire the India-based company Innovcare Lifesciences for approximately Rs2.71 billion, or $28.7 million. This transaction marks a strategic … Sun Pharmaceutical Industries to Acquire Innovcare Lifesciences for Rs2.71 Billion Read More » The post Sun Pharmaceutical Industries to Acquire Innovcare Lifesciences for Rs2.71 Billion first appeared on GeneOnline News. The post Sun Pharmaceutical…

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

According to a regulatory filing, Sun Pharma will buy the entire issued and outstanding share capital of Innovcare Lifesciences via a cash transaction. The company expects to close The post Sun Pharma to acquire Innovcare Lifesciences for $28.7m appeared first on Pharmaceutical Business review.

Sun Pharma rises on inking pact to acquire Innovcare Lifesciences

Mumbai, June 22 (Udaipur Kiran): Sun Pharmaceutical Industries is currently trading at Rs. 1847.95, up by 10.80 points or 0.59% from its previous closing of Rs. 1837.15 on the BSE. The scrip opened at Rs. 1849.70 and has touched a high and low of Rs. 1853.55 and Rs. 1834.20 respectively. So far 16541 shares were traded on the counter. The BSE group ‘A’ stock of face value Rs. 1 has touched a 52 week high of Rs. 1917.15 on 19-May-2026 and a 52 we…